Brief: Hyloris: Positive Results From Phase 2 Trial In Patients With VVC
30/01/2024 06:06
Jan 30 (Reuters) - Hyloris Pharmaceuticals SA HYL.BR :
* HYLORIS AND PURNA FEMALE HEALTHCARE ANNOUNCE POSITIVE
RESULTS
FROM PHASE 2 TRIAL IN PATIENTS WITH ACUTE VULVOVAGINAL
CANDIDIASIS (VVC)
* HYLORIS PHARMACEUTICALS SA - HYLORIS AND PURNA FEMALE
HEALTHCARE
ANNOUNCE POSITIVE RESULTS FROM PHASE 2 TRIAL IN PATIENTS WITH
ACUTE VULVOVAGINAL CANDIDIASIS (VVC)
Source text for Eikon: ID:nGNEb4pmgT
Further company coverage: HYL.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hyloris Pharmaceuticals SA
See all newsEurope Research Roundup: Akzo Nobel, MTU Aero Engines, Symrise
Brief: Hyloris Pharmaceuticals Says It Obtains Exclusive License Rights In Europe & Turkey From Arbormed For Its Wilson's Disease Therapy
Brief: Hyloris Announces Partnership With Rosemont Pharmaceuticals For Atomoxetine Oral Solution In The U.S.
Brief: Hyloris Announces Positive Study Results For Dofetilide IV
Brief: Hyloris Pharmaceuticals SA Says HY 2024 Revenues (Royalties And Milestones) Increased To EUR 4,2 Million